GLYSET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glyset, and what generic alternatives are available?
Glyset is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in GLYSET is miglitol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the miglitol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glyset
A generic version of GLYSET was approved as miglitol by WESTMINSTER PHARMS on February 24th, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLYSET?
- What are the global sales for GLYSET?
- What is Average Wholesale Price for GLYSET?
Summary for GLYSET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Patent Applications: | 4,554 |
| Drug Prices: | Drug price information for GLYSET |
| What excipients (inactive ingredients) are in GLYSET? | GLYSET excipients list |
| DailyMed Link: | GLYSET at DailyMed |
US Patents and Regulatory Information for GLYSET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-001 | Dec 18, 1996 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-002 | Dec 18, 1996 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-003 | Dec 18, 1996 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GLYSET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-001 | Dec 18, 1996 | ⤷ Subscribe | ⤷ Subscribe |
| Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-003 | Dec 18, 1996 | ⤷ Subscribe | ⤷ Subscribe |
| Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-002 | Dec 18, 1996 | ⤷ Subscribe | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GLYSET
See the table below for patents covering GLYSET around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Germany | 2738717 | ⤷ Subscribe | |
| Germany | 20221123 | ⤷ Subscribe | |
| Austria | 378771 | ⤷ Subscribe | |
| Switzerland | 695306 | Filtervorrichtung mit Zigarettenpapier. (Filter device comprises cigarette paper and inner filter and tip located next to each other at one end) | ⤷ Subscribe |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for GLYSET
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0266730 | 98C0014 | Belgium | ⤷ Subscribe | PRODUCT NAME: MIGLITOL; NAT. REGISTRATION NO/DATE: NL 22 138 19970204; FIRST REGISTRATION: NL - 19 343 UR 19960723 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
